Trials / Completed
CompletedNCT05310266
Transversus Abdominis Plane Block Versus Quadratus Lumborum Block for Pain Management in Laparoscopic Appendectomy
Ultrasound-guided Transversus Abdominis Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Appendectomy: A Prospective, Randomized, Controlled Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 168 (actual)
- Sponsor
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Laparoscopic appendectomy causes postoperative pain. The primary objective of this prospective randomized controlled study is to compare the effect of ultrasound (US)-guided quadratus lumborum block (QLB) on 24-hour cumulative opioid requirements with transversus abdominis plane (TAP) block.
Detailed description
168 patients (ASA I-II-III) between 18 and 65 years of age, who were to undergo laparoscopic appendectomy, were randomized and divided into two groups. 32 patients were dropout for different reasons.(68 patients in each of the TAP block and QLB block groups). TAP block was performed for TAP group and QLB block was performed for QLB group. Postoperative analgesia was provided by intravenous tramadol hydrochloride using a patient-controlled analgesia device. 24-hour total tramadol hydrochloride consumption was primary outcome measure.Postoperative numeric rating scale values were the secondary outcome measure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transversus abdominis plane block | The investigators performed transversus abdominis plane block to that patient group for postoperative analgesia |
| PROCEDURE | Quadratus Lumborum Block | The investigators performed quadratus lumborum block to that patient group for postoperative analgesia |
Timeline
- Start date
- 2020-04-06
- Primary completion
- 2021-11-17
- Completion
- 2022-02-21
- First posted
- 2022-04-04
- Last updated
- 2022-07-27
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05310266. Inclusion in this directory is not an endorsement.